Alnylam Pharmaceuticals Inc., of Cambridge, Mass., appointed Laurence Reid senior vice president and chief business officer and named Kenneth Koblan vice president and Distinguished Alnylam Fellow

CMDBioscience, of Orange, Conn., appointed Erick Suchanek and Bernhardt Trout to its scientific advisory board...Satori Pharmaceuticals Inc., of Cambridge, Mass., elected Steven Holtzman chairman of its board of directors and appointed Jeff Jonker chief business officer

Rauch previously was acting head of corporate development for Onyx Pharmaceuticals and served as chief business officer at Point Biomedical and at Onyx

Xcellerex Inc., of Marlborough, Mass., appointed Guy Broadbent president and CEO...The firm's former president and CEO, Joseph Zakrzewski, will remain on with the company as chairman of the board...Silicon Kinetics Inc., of San Diego, named Rick Brown and Eric Topol to its board

Transdel Pharmaceuticals Inc., of La Jolla, Calif., named Terry Nida chief business officer

CEO Appointments: Action Pharma, of Holte, Denmark, has appointed Ingelise Saunders as CEO...Epizyme Inc., of Cambridge, Mass., appointed Robert Gould as CEO and Jason Rhodes as executive vice president and chief business officer

Tekmira Pharmaceuticals Corp., of Vancouver, British Columbia, appointed Daniel Kisner chairman and named Kenneth Galbraith and Frank Karbe to its board...Xencor Inc., of Monrovia, Calif., appointed Edgardo Baracchini chief business officer

Tom Amick will serve as president and CEO, while Edward L. Field was named executive vice president and chief business officer

BIND Biosciences Inc., of Cambridge, Mass., appointed Scott Minick president and CEO...Constellation Pharmaceuticals Inc., of Cambridge, Mass., appointed Kerry K. Reinertsen chief business officer...CrystalGenomics Inc., of Seoul, South Korea, and CG Pharmaceuticals Inc., of Emeryville, Calif., appointed Eric M. Nelson vice president of business development

operations, Karen Hodgkin head of clinical development and Tina Crombie head of business administration...ConvaTec, of Paris, named Erik Zimmer vice president and general manager within its European, Middle East and Africa region...Medivation Inc., of San Francisco, said Chief Financial Officer Patrick Machado will become chief business officer and Karen Reeves will be senior vice president of clinical development

Oxygen Biotherapeutics Inc., of Durham, N.C., added Rene A. Eckert and William A. Chatfield to its board...Santaris Pharma A/S, of Horsholm, Denmark, added Mark Wedel as vice president and chief medical officer and Stuart Mackey as vice president of strategy and chief business officer

Burnham Institute for Medical Research, of La Jolla, Calif., appointed Paul Laikind senior vice president of business development and chief business officer...DBV Technologies, of Paris, added Gideon Lack and Philippe Eigenmann to its scientific advisory board

Burnham Institute for Medical Research, of La Jolla, Calif., appointed Paul Laikind senior vice president of business development and chief business officer...DBV Technologies, of Paris, added Gideon Lack and Philippe Eigenmann to its scientific advisory board

Apthera Inc., of Scottsdale, Ariz., appointed Ira Z. Leiderman executive chairman and named Mary Ann Gray to the board...Dendreon Corp., of Seattle, elected Ian Clark and Pedro Granadillo to its board...NeoStem Inc., of New York, named Teresa Lepore vice president, sales and marketing

Trinity Biosystems, of Menlo Park, Calif., appointed René Castro chief business officer

BiPar Sciences, of San Francisco, appointed G. Kirk Raab chairman and John Schembri as chief financial officer to its TriAct Therapeutics company...EnVivo Pharmaceuticals, of Watertown, Mass., appointed Stephen J. DiPalma senior vice president and chief financial officer...Quanterix Corp., of Cambridge, Mass., appointed David Okrongly CEO and a member of the company's board of directors

PharmAthene Inc., of Annapolis, Md., appointed Charles A. Reinhart III senior vice president and chief financial officer...Symphogen A/S, of Copenhagen, Denmark, named Adriann Sax chief business officer

Symphogen A/S, of Copenhagen, Denmark, named Adriann Sax chief business officer...Third Rock Ventures LLC, of Boston, appointed Philip R. Reilly and Gregory L. Verdine venture partners, and Craig M. Greaves recruiting partner

Nuon Therapeutics Inc., of San Mateo, Calif., appointed Paulette Dillon chief business officer and Tito Serafini chief scientific officer